The largest database of trusted experimental protocols

Architect i1000 analyzer

Manufactured by Abbott
Sourced in Germany, United States

The Architect i1000 analyzer is a compact, fully automated immunoassay system designed for routine clinical laboratory testing. It is capable of performing a wide range of immunoassay tests, including those for hormones, therapeutic drug monitoring, and infectious disease diagnostics. The analyzer is equipped with advanced technological features to ensure efficient and reliable operation.

Automatically generated - may contain errors

9 protocols using architect i1000 analyzer

1

Fasting Blood Sample Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
EDTA blood samples were collected in a fasting state for measurement of creatinine (Cr), estimated glomerular filtration rate (eGFR), albumin, total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, and hemoglobin A1C (Hgb A1C) if patients were diabetic. Plasma was assayed for these analytes on the same day as collection by the SF VAMC lab per standard methodology (Beckman Coulter Analyzer). Serum was isolated at the same time points as described above and assayed for homocysteine on the same day as collection by the SF VAMC lab per standard methodology (Abbott Diagnostics Architect i1000 Analyzer, Lake Forest, IL).]
+ Open protocol
+ Expand
2

Biomarker Measurement in Serum Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
All samples were obtained by venipuncture into serum monovette® and centrifuged at 2500 ×g at 20°C for 10 minutes. The aliquoted samples were stored at −80°C until analysis. After thawing the samples were mixed gently by inverting and centrifuged with 2500 ×g for 10 minutes.
Galectin-3 was measured with the Galectin-3 assay on an Architect i1000 analyzer (Abbott, Wiesbaden, Germany). The limit of blank for this assay was 0.8 ng/mL as described in the instructions for use [20 ]. NT-proBNP was measured with the proBNP II STAT assay on a cobas e 602 analyzer (Roche Diagnostics, Mannheim, Germany). The limit of detection (LoD) for this assay was 5 pg/mL [21 ]. Serum creatinine was measured with the Creatinine Jaffe Gen. 2 assay on a cobas c 702 analyzer (Roche Diagnostics, Mannheim, Germany).
+ Open protocol
+ Expand
3

Standardized Biomarker Measurement in Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
All expressed biomarkers were measured in the serum of patients’ blood. All samples were obtained by venipuncture into serum monovettes® and centrifuged at 2000 g for 10 min at 20 °C. The aliquoted samples were cooled down with liquid nitrogen before being stored at − 80 °C until analysis. The complete processing was conducted within two hours after blood extraction. After thawing, the samples were mixed gently by inverting and centrifuged with 2500g for 10 min at 20 °C, respectively, 3000g for 30 min for hsTnI at 4 °C.
HsTnT was measured with the Troponin T hs STAT assay on a cobas e 602 analyzer (Roche Diagnostics, Mannheim, Germany). The limit of blank (LoB) for this assay was 3 ng/L and the limit of detection (LoD) was 5 ng/L as described in the instructions for use [15 ]. HsTnI was measured with the STAT High sensitivity Troponin-I assay on an Architect i1000 analyzer (Abbott, Wiesbaden, Germany). The LoB was 0.7–1.3 ng/L and the LoD was 1.1–1.9 ng/L for this assay as described in the instructions for use [16 ]. NT-proBNP was measured with the proBNP II STAT assay on a cobas e 602 analyzer (Roche Diagnostics, Mannheim, Germany). The LoD for this assay was 5 ng/L [17 ]. Creatinine was measured with the Creatinine Jaffe Gen.2 assay on a cobas c 702 analyzer (Roche Diagnostics, Mannheim, Germany).
+ Open protocol
+ Expand
4

Serum Biomarker Profile Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting blood samples were collected for measuring serum 25(OH) D, albumin, iPTH, alkaline phosphate, plasma homocysteine levels, and lipid profiles. Serum 25(OH)D was measured using ELISA (Immunodiagnostic Systems Inc., Fountain Hills, AZ, USA) that detected both vitamins D2 and D3, with a detection limit of 5.0 nmol/L. Intact PTH was measured using an iPTH immunoradiometric assay (IRMA; Scantibodies Laboratory, Inc., Santee, CA, USA) with a normal range of 8–76 pg/mL. Serum cholesterol was determined with an enzymatic photometric assay using a Hitachi 7600 analyzer (Roche, Hitachi system, Tokyo, Japan). Serum high-density lipoprotein (HDL) and low-density lipoprotein (LDL) levels were determined using homogeneous enzymatic colorimetric assays (Sekisui, Osaka, Japan); the coefficient of variation (CV) was 2.08% and 2.61%, respectively. Serum triglycerides were assessed with an enzymatic photometric assay (CHO-HMMPS method) (WAKO, Osaka, Japan), with a CV of 1.98%. Serum homocysteine and vitamin B12 levels were determined using the chemiluminescent microparticle immunoassay method on an Architect i1000 analyzer (Abbott, MA, USA).
+ Open protocol
+ Expand
5

Biomarker Measurement Protocol for Clinical Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected from all patients (at rest) at a single assessment time point upon study inclusion by venepuncture with serum monovettes and centrifuged at 2,500 g at 20℃ for 10 minutes. The aliquoted samples were cooled down in liquid nitrogen before being stored at −80℃ for further analysis. After thawing, the samples were mixed gently by inverting and centrifuged at 2,500 g for 10 minutes at 20℃.
Gal-3 levels were assessed using the Gal-3 assay on an Architect i1000 analyzer (Abbott, Wiesbaden, Germany). The limit of blank for this assay was 0.8 ng/mL, as specified in the user instructions (Galectin-3, Architect System, © 2012, 2013 Abbott Laboratories). Serum creatinine concentrations were measured using the Creatinine Jaffe Gen.2 assay on a Cobas c 702 analyzer (Roche Diagnostics, Mannheim, Germany), and the glomerular filtration rate (eGFR) was estimated using the Modification of Diet in Renal disease (MDRD) formula (Instructions for use, Cobas c 702 analyzer). The serum level of NT-proBNP, used as a reference biomarker, was measured using a proBNP II STAT assay on a Cobas e 602 analyzer (Roche Diagnostics). The limit of detection (LoD) for this assay was 5 pg/mL (proBNP II STAT, Cobas®, © 2014, Roche Diagnostics).
+ Open protocol
+ Expand
6

Biomarker Quantification in Serum Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
All expressed biomarkers were measured in the serum of patients' blood. All samples were obtained by venipuncture into serum monovettes Õ and centrifuged at 2500 g for 10 min at 20 C. The aliquoted samples were cooled down with liquid nitrogen before being stored at À80 C until analysis. The complete processing was conducted within 2 h after blood extraction. After thawing, the samples were mixed gently by inverting and centrifuged with 2500 g for 10 min at 20 C, respectively, 3000 g for 30 min for hsTnI at 4 C.
HsTnT was measured with the Troponin T hs STAT assay on a cobas e 602 analyzer (Roche Diagnostics, Mannheim, Germany). The limit of blank (LoB) for this assay was 3 ng/L and the limit of detection (LoD) was 5 ng/L as described in the instructions for use. 29 HsTnI was measured with the STAT High sensitivity Troponin-I assay on an Architect i1000 analyzer (Abbott, Wiesbaden, Germany). The limit of blank (LoB) was 0.7-1.3 ng/L for this assay as described in the instructions for use. 30 NT-proBNP was measured with the proBNP II STAT assay on a cobas e 602 analyzer (Roche Diagnostics, Mannheim, Germany). The LoD for this assay was 5 ng/L. 31 Creatinine was measured with the Creatinine Jaffe Gen.2 assay on a cobas c 702 analyzer (Roche Diagnostics, Mannheim, Germany).
+ Open protocol
+ Expand
7

Biomarker Profiling of Metabolic Health

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected in a fasting state for measurement of albumin, total cholesterol, triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), soluble intercellular adhesion molecule-1 (sICAM-1), tumor-necrosis-factor-α (TNF-α), and hemoglobin A1C (Hgb A1C). Plasma was assayed for albumin, total cholesterol, triglycerides, LDL, HDL, hsCRP, Hgb A1C on the same day as collection by the SF VAMC lab per standard methodology (Beckman Coulter Analyzer). The coefficient of variation for hsCRP using this procedure is 5.1%. Serum was isolated at the same time points for homocysteine and assayed the same day as collection by the SF VAMC lab per standard methodology (Abbott Diagnostics Architect i1000 Analyzer, Lake Forest, IL). Serum was processed per standard protocol and stored at −80°C until assayed for IL-6, sICAM-1, and TNF-α per standard kit protocol (R&D Systems Inc., Minneapolis, MN). The typical coefficients of variation for IL-6, sICAM-1, and TNF-α are 7.4%, 4.6%, and 5.4%, respectively. The lower limits of detection are 0.04pg/ml, 0.1ng/ml, and 0.11pg/ml, respectively.
+ Open protocol
+ Expand
8

Quantitative Hepatitis B Serology

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Architect i1000 analyzer (Abbott Diagnostics, Abbott Park, IL, USA), which uses a chemiluminescent microparticle immunoassay (CMIA), was used to analyze HBsAg, HBeAg, and anti-HBe antibodies. Serum HBsAg was determined quantitatively, whereas serum HBeAg and anti-HBe were determined qualitatively. Analysis of these serological markers was conducted according to the manufacturer’s protocol.
+ Open protocol
+ Expand
9

Comprehensive Metabolic Profiling of Fasting Subjects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected from subjects in a fasting state for measurement of creatinine, estimated glomerular filtration rate, albumin, hemoglobin A1C as well as total cholesterol, triglycerides, low-density lipoprotein, and high-density lipoprotein. Plasma was assayed for these analytes the same day as collection by the SFVAMC lab per standard methodology (Beckman Coulter Analyzer). Serum was isolated at the same time points for homocysteine and assayed the same day as collection by the SFVAMC lab per standard methodology (Abbott Diagnostics Architect i1000 Analyzer, Lake Forest, IL).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!